Bona Film Group (Nasdaq: BONA) reported earnings on Nov. 15. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Bona Film Group missed estimates on revenues and beat expectations on earnings per share.

Compared to the prior-year quarter, revenue dropped significantly and GAAP earnings per share shrank significantly.

Margins shrank across the board.

Revenue details
Bona Film Group recorded revenue of $24.6 million. The four analysts polled by S&P Capital IQ anticipated revenue of $26.9 million on the same basis. GAAP reported sales were 34% lower than the prior-year quarter's $37.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.09. The three earnings estimates compiled by S&P Capital IQ averaged $0.04 per share. GAAP EPS of $0.02 for Q3 were 85% lower than the prior-year quarter's $0.13 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 54.6%, 340 basis points worse than the prior-year quarter. Operating margin was 3.3%, 1,860 basis points worse than the prior-year quarter. Net margin was 5.3%, 1,460 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $70.2 million. On the bottom line, the average EPS estimate is $0.22.

Next year's average estimate for revenue is $166.8 million. The average EPS estimate is $0.35.

Investor sentiment
The stock has a one-star rating (out of five) at Motley Fool CAPS, with nine members out of 28 rating the stock outperform, and 19 members rating it underperform. Among 17 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), three give Bona Film Group a green thumbs-up, and 14 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Bona Film Group is outperform, with an average price target of $7.03.